Yuanbao Inc.
YBTechnologyNASDAQSoftware - Application
Scan Results
Daily timeframeYuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. The company carries a $528.1M market cap, placing it firmly in the small-cap category. The company offers medical, critical illness, accident, property, and pet insurance products.
Market Cap
$528.1M
Beta
—
P/E (TTM)
2.58
P/E (Fwd)
2.27
EPS (TTM)
$4.44
EPS (Fwd)
$5.05
ROE
47.2%
ROA
20.7%
Cash
$5.14B
Total Debt
$1.6M
Free CF
—
52W Change
-52.3%
Annual Financials
Cash vs Debt
Where YB stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, YB finished 21.66% below its 150-day moving average ($14.22) and 27.09% below its 200-day moving average ($15.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is YB overbought or oversold?
At the October 15, 2026 close, YB's RSI(14) was 35.2, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Yuanbao Inc. holds $5.14B in cash against $1.6M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Return on equity stands at 47.2%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 20.7% further supports the picture of efficient asset utilization. Revenue has grown from $850.2M (2022) to $4.37B (2025), reflecting a 414% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Yuanbao Inc.'s trajectory.